Please ensure Javascript is enabled for purposes of website accessibility

Aphria Subsidiary Earns European Union's GMP Certification

By Aditya Raghunath – May 6, 2020 at 3:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis company expects the certification will help it boost its presence in Europe.

Today, cannabis company Aphria (APHA) announced that its  subsidiary in Malta, ASG Pharma, has received the European Union's Good Manufacturing Practices (GMP) certification.

This certification was issued by the Malta Medicines Authority and allows Aphria to produce and research medical marijuana products at its facility. Aphria can now import cannabis resin and dried flowers, and package and distribute GMP-compliant cannabis products all across Europe.

Person extracting cannabis oil from a bottle

Image source: Getty Images.

During its last earnings call, Aphria confirmed that the analytical laboratory it's constructing in Malta will be fully operational in the second half of its fiscal 2020, which ends May 31. The company will perform cannabis processing and packaging operations at the same facility.

Though Malta is a small country, Aphria will now be able to ship its products to other EU member states where medical marijuana use is legal. Earlier this year, Aphria received GMP certifications for its Aphria One Facility in Ontario, as well as for another subsidiary, Avanti Rx Analytics.

The certification will help the Canada-based marijuana leader to gain traction in the medical cannabis segment, a high growth market in Europe.

"We are pleased to receive EU GMP certification for ASG in Malta, our third facility to achieve this milestone, which really speaks to the Company's commitment to quality," Aphria CEO Irwin D. Simon said. "We remain excited about growth opportunities as this increases our ability to serve, and further strengthens Aphria's leadership, in the European Union."

Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.